Es gab 31 kürzliche Insider-Transaktionen für MIRA Pharmaceuticals, Inc. (MIRA), darunter 22 Käufe und 4 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $6.6M und die gesamten Insider-Verkäufe auf $575.65K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Aminov Erez, Shekhat Denil Nanji, Weichselbaum Alan. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — MIRA
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-30 |
Aminov Erez |
Chief Executive Officer |
RSU-Zuteilung |
83,500 |
- |
- |
83,500 |
| 2025-12-17 |
Aminov Erez |
CEO and Chairman |
RSU-Zuteilung |
3,155,170 |
$1.45 |
$4.57M |
3,155,170 |
| 2025-10-16 |
Aminov Erez |
CEO and Chairman |
Optionsausübung |
234,595 |
$1.16 |
$272.13K |
234,595 |
| 2025-10-01 |
Aminov Erez |
Chief Executive Officer |
RSU-Zuteilung |
2,685,456 |
- |
- |
3,530,156 |
| 2025-10-01 |
Shekhat Denil Nanji |
Director |
RSU-Zuteilung |
22,378 |
$1.35 |
$30.21K |
22,378 |
| 2025-09-18 |
Aminov Erez |
Chief Executive Officer |
RSU-Zuteilung |
150,000 |
$1.38 |
$207K |
150,000 |
| 2025-08-29 |
Aminov Erez |
Chief Executive Officer |
RSU-Zuteilung |
62,500 |
$1.37 |
$85.63K |
844,700 |
| 2025-05-15 |
Weichselbaum Alan |
Chief Financial Officer |
Unbekannt |
75,000 |
$1.18 |
$88.5K |
- |
| 2024-12-09 |
Yanez Michelle |
Chief Financial Officer |
RSU-Zuteilung |
150,000 |
$1.19 |
$178.5K |
150,000 |
| 2024-12-09 |
Aminov Erez |
Chief Executive Officer |
RSU-Zuteilung |
500,000 |
- |
- |
500,000 |
| 2024-12-09 |
Macpherson Edward Clouston |
Director |
RSU-Zuteilung |
25,000 |
$1.19 |
$29.75K |
25,000 |
| 2024-12-09 |
Shekhat Denil Nanji |
Director |
RSU-Zuteilung |
50,000 |
$1.19 |
$59.5K |
50,000 |
| 2024-12-09 |
Del Giudice Matthew Paul |
Director |
RSU-Zuteilung |
25,000 |
$1.19 |
$29.75K |
75,000 |
| 2024-12-09 |
Whalen Matthew Pratt |
Director |
RSU-Zuteilung |
25,000 |
$1.19 |
$29.75K |
25,000 |
| 2024-11-20 |
Aminov Erez |
Chief Executive Officer |
Informierter Verkauf |
44,590 |
$1.27 |
$56.63K |
1,061,200 |
| 2024-11-19 |
Aminov Erez |
Chief Executive Officer |
Informierter Verkauf |
55,410 |
$1.39 |
$77.02K |
1,105,790 |
| 2024-11-18 |
Whalen Matthew Pratt |
Director |
Unbekannt |
- |
- |
- |
- |
| 2024-08-28 |
Mcnulty Brian Patrick |
10 Percent Owner |
Informierter Verkauf |
200,000 |
$1.96 |
$392K |
2,540,270 |
| 2024-06-18 |
Shekhat Denil Nanji |
Director |
RSU-Zuteilung |
50,000 |
$0.71 |
$35.5K |
41,666 |
| 2024-05-28 |
Aminov Erez |
Chief Executive Officer |
RSU-Zuteilung |
379,000 |
$0.84 |
$318.36K |
629,000 |
| 2024-05-21 |
Aminov Erez |
Chief Executive Officer |
Informierter Kauf |
2,000 |
$1.00 |
$2K |
375,500 |
| 2024-03-26 |
Yanez Michelle |
Chief Financial Officer |
RSU-Zuteilung |
150,000 |
$1.15 |
$172.5K |
57,799 |
| 2024-03-26 |
Aminov Erez |
Chief Executive Officer |
RSU-Zuteilung |
300,000 |
$1.15 |
$345K |
250,000 |
| 2024-03-25 |
Jerman Michael Allen |
Director |
RSU-Zuteilung |
50,000 |
$1.16 |
$58K |
25,000 |
| 2024-03-25 |
Macpherson Edward Clouston |
Director |
RSU-Zuteilung |
50,000 |
$1.16 |
$58K |
25,000 |
| 2024-03-25 |
Shekhat Denil Nanji |
Director |
RSU-Zuteilung |
50,000 |
$1.16 |
$58K |
25,000 |
| 2024-03-25 |
Del Giudice Matthew Paul |
Director |
RSU-Zuteilung |
50,000 |
$1.16 |
$58K |
25,000 |
| 2024-03-13 |
Macpherson Edward Clouston |
Director |
Unbekannt |
- |
- |
- |
- |
| 2024-03-13 |
Shekhat Denil Nanji |
Director |
Unbekannt |
- |
- |
- |
- |
| 2024-03-13 |
Del Giudice Matthew Paul |
Director |
Unbekannt |
- |
- |
- |
- |
| 2023-08-02 |
Vorhoff David C |
Director |
Veräußerung |
10,000 |
$5.00 |
$50K |
- |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
